Denise Alveranga is categorized under Physical Medicine, Physician/Surgeon in Tampa, FL and active since 2011.
Denise Alveranga was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Denise Alveranga at the company’s single location by writing to 409 Bayshore Boulevard, Tampa, Florida FL 33606 or by phoning (813) 251-8017. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Denise Alveranga |
| Contact Person: | Denise Alveranga |
| Address: | 409 Bayshore Boulevard, Tampa, Florida 33606 |
| Phone Number: | (813) 251-8017 |
| Website Address: | tgmg.org |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Denise Alveranga was started in 2011 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Denise Alveranga for inquiries that concern Denise Alveranga by calling the company number (813) 251-8017, as your correspondence is most welcome. Additionally, the physical location of the single location of Denise Alveranga can be found at the coordinates 27.939102,-82.461694 as well as the street address 409 Bayshore Boulevard in Tampa, Florida 33606.
For its online presence, you may visit Denise Alveranga’s website at tgmg.org and engage with its social media outlets through on Twitter and on Facebook.